The IPO Market Is Heating Up Again. These Financial Stocks Stand to Win.

The article argues that anticipated IPOs from SpaceX, OpenAI, and Anthropic could boost underwriters Goldman Sachs and Morgan Stanley, while also increasing trading activity for brokers such as Interactive Brokers and Robinhood. It frames IPO booms as sentiment-driven and notes that underwriters and brokers can benefit regardless of post-listing share performance. The piece is mainly thematic commentary rather than a company-specific catalyst, so expected market impact is modest.

Analysis

The second-order winner here is not the IPO names but the liquidity layer that monetizes speculation around them. GS and MS should capture the underwriting and advisory fees up front, but the bigger recurring P&L lever is post-deal market-making, financing, and prime-brokerage activity if these listings catalyze a broader reopening in late-stage private-market exits. IBKR is arguably the cleaner lever because it monetizes the turnover surge regardless of whether the IPOs are viewed as hot or disappointing; a high-profile deal slate can lift funded accounts and trading frequency for months, not just the listing week.

The market is likely underestimating how much this can spill into adjacent assets. A strong IPO window typically compresses discounts across private markets, which can force VC-backed companies to mark up portfolios and re-engage with public comps, feeding a valuation feedback loop into AI/tech sentiment. That is modestly supportive for NVDA/INTC only indirectly through sentiment and capital-allocation optics, but the more immediate trade is broker beta and capital-markets leverage, not chip fundamentals.

The main risk is that the IPO narrative gets crowded before cash flows show up. If the first deals are priced aggressively and then trade poorly, retail enthusiasm can fade quickly, muting volumes and hurting the “feed the frenzy” dynamic within days to weeks. Over a 3-6 month horizon, the larger reversal catalyst would be a drawdown in equity indices or a volatility spike, which tends to shut the IPO window faster than company-specific news can reopen it.

Consensus is probably too focused on a binary 'IPO winners vs losers' framing. The better lens is volatility monetization: the best risk-adjusted exposure is to the platforms that earn on activity, not the issuers whose post-IPO path is unknowable. If this becomes a true reopening cycle, the asymmetry is in IBKR and MS/GS operating leverage, while the downside is mostly limited to lower-than-expected deal flow rather than permanent damage.

Key Decisions for Investors

• Long IBKR vs short a basket of high-duration mega-cap growth proxies for 1-3 months; thesis is that IPO hype lifts retail turnover even if first-day performance is mixed. Risk/reward is favorable because IBKR monetizes activity across multiple sessions, while the short leg hedges a fade in speculative sentiment.
• Add GS and MS on weakness into the pre-IPO news cycle for a 3-6 month trade; target is capital-markets fee uplift and secondary trading revenues if the window opens. Use a 10-15% trailing stop because the main risk is a delayed or poorly received debut slate.
• Sell short-dated puts on IBKR into any volatility spike ahead of major IPO filings; implied vol should overprice the probability of a retail frenzy that may already be partly reflected. Best if entered after a sharp 1-2 week run, with defined downside to the strike.
• Pair long MS / short XLF if you want to express a 'capital markets beats passive bank beta' view; MS has cleaner exposure to underwriting and wealth/prime brokerage tailwinds. Expect modest outperformance over 1-2 quarters if issuance rebounds.
• Avoid chasing the eventual IPOs at the open; instead, wait 3-5 sessions for volume normalization and then buy only if trading activity remains elevated. The key risk is paying for narrative momentum that can reverse immediately after lockup and allocation dynamics settle.